Navitoclax

Overview

Navitoclax is an oral BCL-2 inhibitor that is being studied for use in several different cancers.

SparkCures ID 540
Generic Name Navitoclax
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.